XML 69 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation, Stock Option Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Unamortized Stock Compensation Expense [Abstract]    
Unamortized stock compensation expense $ 11,800,706  
Weighted-average grant date fair value, granted (in dollars per share) $ 7.65 $ 1.14
Stock Options [Member]    
Number of Shares [Roll Forward]    
Options outstanding, beginning balance (in shares) 1,650,897  
Granted (in shares) 1,958,030  
Exercised (in shares) (117,958)  
Forfeited (in shares) (327,134)  
Options outstanding, ending balance (in shares) 3,163,835 1,650,897
Vested and expected to vest (in shares) 3,163,835  
Exercisable (in shares) 1,437,539  
Weighted Average Exercise Price [Roll Forward]    
Options outstanding, beginning balance (in dollars per share) $ 11.87  
Granted (in dollars per share) 4.35  
Exercised (in dollars per share) 6.59  
Forfeited (in dollars per share) 29.67  
Options outstanding, ending balance (in dollars per share) 5.57 $ 11.87
Vested and expected to vest (in dollars per share) 5.57  
Exercisable (in dollars per share) $ 6.55  
Weighted Average Remaining Contractual Life and Aggregate Intrinsic Value [Abstract]    
Options outstanding, weighted average remaining contractual life 7 years 10 months 24 days 7 years 10 days
Granted, weighted average remaining contractual life 9 years 1 month 9 days  
Vested and expected to vest, weighted average contractual life 7 years 10 months 24 days  
Exercisable, weighted average contractual life 6 years 4 months 28 days  
Options outstanding, aggregate intrinsic value $ 226,731  
Granted, aggregate intrinsic value 8,803,138  
Exercised, aggregate intrinsic value 0  
Forfeited, aggregate intrinsic value 0  
Options outstanding, aggregate intrinsic value 10,839,589 $ 226,731
Vested and expected to vest, aggregate intrinsic value 10,839,589  
Exercisable, aggregate intrinsic value $ 0  
Unamortized Stock Compensation Expense [Abstract]    
Period for recognition 2 years 10 months 20 days  
Weighted-average grant date fair value, granted (in dollars per share) $ 7.65